Bachelor of Business Administration – International Trade, University of Central Arkansas, United States of America.
Senior Management Development Programme, Harvard Business School
Working Experience and Occupation
Wan Amir-Jeffery began his career in a marine and environmental consulting firm called Sea Resources Management (“SRM”) Sdn. Bhd. in 1997. In 2007, he left SRM to join Malaysian Biotechnology Corporation (“BiotechCorp”) Sdn. Bhd. as Lead Business Analyst, Biomedical Business Development and Investment (“BDI”) Division. At BiotechCorp, he developed his knowledge and expertise in identifying, structuring, securing and implementing biomedical investment projects, especially in the biopharma and pharmaceutical industries. He was promoted to Vice-President within the same division in 2008.
In 2013, he assumed the dual role of Chief Executive Officer of Johor Biotechnology & Biodiversity Corporation and J-Biotech Holdings Sdn. Bhd. He was responsible for developing and implementing key bioeconomy and biotech initiatives in Johor. Wan Amir-Jeffery joined CCM Duopharma Biotech Berhad as Chief Strategy Officer on 5 September 2016, responsible for business development, Halal initiatives and government business sales of CCM Duopharma and appointed as Chief Operating Officer on 12 September 2018. He is also the Chief Executive Officer of Duopharma (M) Sendirian Berhad, a wholly owned subsidiary of CCM Duopharma since 5 September 2016.